Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 16/702,236, filed Dec 3, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,712,428 | Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity In force · Medium confidence | Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited | In force | Medium confidence | ||
| US 11,712,429 | Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity In force · Medium confidence | Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited | In force | Medium confidence | ||
| Application 16/179,623 | Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity Abandoned Abandoned May 2, 2022 | Amarin Pharmaceuticals Ireland Limited | Abandoned | Abandoned May 2, 2022 | ||
| Application 16/702,236 | Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity Abandoned Abandoned Mar 3, 2022 | Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited | Abandoned | Abandoned Mar 3, 2022 | ||
| Application 17/675,596 | Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity Abandoned Abandoned Dec 4, 2024 | Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited | Abandoned | Abandoned Dec 4, 2024 |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Amarin Pharma, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.